|
| |
| | | 67482 | | 04.05.2021 | | Vifor (International) AG | | | | | | | 03.05.2026 | | | | | | 08.08. | | | | 08.08. | | IPro |
| | Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
|---|
| 01 | Flucelvax Tetra | Injektionssuspension | Suspension injectable (Haemagglutininum Influenzae a (H3N2) (Virus Stamm A/kansas/14/2017 (H3N2)-Like: Derived from A/indiana/08/2018) 15µg / 0.5ml, Haemagglutininum Influenzae a (H1N1) (Virus Stamm A/brisbane/02/2018 (H1N1)-Like: Derived from A/idaho/07/2018) 15µg / 0.5ml, Haemagglutininum Influenzae b (Virus Stamm B/colorado/06/2017-Like: Reassortant from B/iowa/06/2017 (Victoria Lineage)) 15µg / 0.5ml) | J07BB02 | | | 02 | Flucelvax Tetra | Injektionssuspension | Suspension injectable (Haemagglutininum Influenzae a (H1N1) (Virus Stamm A/wisconsin/67/2022 (H1N1)-Like: Derived from A/georgia/12/2022 Cvr-167) 15µg / 0.5ml, Haemagglutininum Influenzae a (H3N2) (Virus Stamm A/massachusetts/18/2022 (H3N2)-Like: Derived from A/sydney/1304/2022) 15µg / 0.5ml, Haemagglutininum Influenzae b (Virus Stamm B/austria/1359417/2021-Like: Reassortant from B/singapore/wuh4618/2021 (Victoria Lineage)) 15µg / 0.5ml) | J07BB02 | |
|
|
|
